In the central nervous system, myelination of axons occurs when oligodendrocyte progenitors undergo terminal differentiation and initiate process formation and axonal ensheathment. Although it is hypothesized that neuron-oligodendrocyte contact initiates this process, the molecular signals are not known. Here we find that Fyn tyrosine kinase activity is upregulated very early during oligodendrocyte progenitor cell differentiation. Concomitant with this increase is the appearance of several tyrosine phosphorylated proteins present only in differentiated cells. The increased tyrosine kinase activity is specific to Fyn, as other Src family members are not active in oligodendrocytes. To investigate the function of Fyn activation on differentiation, we used Src family tyrosine kinase inhibitors, PP1 and PP2, in cultures of differentiating oligodendrocyte progenitors. Treatment of progenitors with these compounds prevented activation of Fyn and reduced process extension and myelin membrane formation. This inhibition was reversible and not observed with related inactive analogues. A similar effect was observed when a dominant negative Fyn was introduced in progenitor cells. These findings strongly suggest that activation of Fyn is an essential signaling component for the morphological differentiation of oligodendrocytes.
Skip Nav Destination
Article navigation
14 June 1999
Article|
June 14 1999
Morphological Differentiation of Oligodendrocytes Requires Activation of Fyn Tyrosine Kinase
Donna J. Osterhout,
Donna J. Osterhout
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Search for other works by this author on:
Amy Wolven,
Amy Wolven
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Search for other works by this author on:
Rebecca M. Wolf,
Rebecca M. Wolf
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Search for other works by this author on:
Marilyn D. Resh,
Marilyn D. Resh
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Search for other works by this author on:
Moses V. Chao
Moses V. Chao
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Search for other works by this author on:
Donna J. Osterhout
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Amy Wolven
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Rebecca M. Wolf
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Marilyn D. Resh
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Moses V. Chao
*Molecular Neurobiology Program, Skirball Institute, New York University Medical Center, New York 10016; ‡Molecular Biology Program, Cornell University Medical College, New York; and §Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York 10021
Address correspondence to Moses V. Chao, Molecular Neurobiology Program, Skirball Institute, NYU Medical Center, 540 First Ave., New York, NY 10016. Tel.: (212) 263-0721. Fax: (212) 263-8214. E-mail: [email protected]
The first two authors contributed equally to this manuscript.
Received:
November 25 1998
Revision Received:
May 04 1999
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1999
J Cell Biol (1999) 145 (6): 1209–1218.
Article history
Received:
November 25 1998
Revision Received:
May 04 1999
Citation
Donna J. Osterhout, Amy Wolven, Rebecca M. Wolf, Marilyn D. Resh, Moses V. Chao; Morphological Differentiation of Oligodendrocytes Requires Activation of Fyn Tyrosine Kinase . J Cell Biol 14 June 1999; 145 (6): 1209–1218. doi: https://doi.org/10.1083/jcb.145.6.1209
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement